Invitae Corporation
NVTA
Ранг среди акций
#35791
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Цена акции
$0.016
Последняя синхронизация: 2024-03-11
Рыночная капитализация
$3.27M
Изменение (1 день)
-5.33%
Изменение (1 год)
5,233.33%
Страна
US
Торговля Invitae Corporation (NVTA)
Категория
Healthcare
EPS для Invitae Corporation (NVTA)
EPS по состоянию на September 2023 TTM: $-5.38
Согласно последним финансовым отчетам и цене акций Invitae Corporation, текущий EPS компании (TTM) составляет $-5.38. В конце 2022 EPS компании составлял $-13.18, больше, чем показателю 2021 года, равному $-1.80.
История EPS компании Invitae Corporation с 2016 по 2026
EPS на конец каждого года
| Год | EPS | Изменить |
|---|---|---|
| 2026 (TTM) | $-5.38 | -100.00% |
| 2023 | 0.00 | -100.00% |
| 2022 | $-13.18 | 632.22% |
| 2021 | $-1.80 | -59.73% |
| 2020 | $-4.47 | 68.05% |
| 2019 | $-2.66 | 37.11% |
| 2018 | $-1.94 | -26.79% |
| 2017 | $-2.65 | -12.25% |
| 2016 | $-3.02 | 0.00% |
EPS для аналогичных компаний или конкурентов
| Компания | EPS | Разница в EPS | Страна |
|---|---|---|---|
| $18.62 | -446.10% |
US
|
|
| $5.65 | -205.02% |
US
|
|
| $-1.36 | -74.72% |
US
|
|
| - | - |
CN
|
|
| $5.09 | -194.61% |
US
|
